Scholars@Duke
Journal cover image

Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study

Publication ,  Conference
Published in: Journal of the American Academy of Dermatology
June 2017
Published version (DOI) Publisher Link

Duke Scholars

Megan Elizabeth Bowles Clowse
Author Megan Elizabeth Bowles Clowse Medicine, Rheumatology and Immunology

Published In

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2017.04.499

ISSN

0190-9622

Publication Date

June 2017

Volume

76

Issue

6

Start / End Page

AB127 / AB127

Publisher

Elsevier BV

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study. (2017). In Journal of the American Academy of Dermatology (Vol. 76, pp. AB127–AB127). Elsevier BV. https://doi.org/10.1016/j.jaad.2017.04.499
“Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study.” In Journal of the American Academy of Dermatology, 76:AB127–AB127. Elsevier BV, 2017. https://doi.org/10.1016/j.jaad.2017.04.499.
“Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study.” Journal of the American Academy of Dermatology, vol. 76, no. 6, Elsevier BV, 2017, pp. AB127–AB127. Crossref, doi:10.1016/j.jaad.2017.04.499.
Journal cover image

Published In

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2017.04.499

ISSN

0190-9622

Publication Date

June 2017

Volume

76

Issue

6

Start / End Page

AB127 / AB127

Publisher

Elsevier BV

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1103 Clinical Sciences